Spectral AI to Participate in Upcoming Investor Conferences
Spectral AI (Nasdaq: MDAI), an AI company specializing in medical diagnostics for wound care, has announced its participation in two upcoming investor conferences in New York City. Peter M. Carlson, CEO, and Vince Capone, CFO, will represent the company at these events:
1. H.C. Wainwright 26th Annual Global Investment Conference (September 9-11, 2024): A virtual fireside chat will be available from September 9 at 7:00 am ET, accessible via the company's website. One-on-one meetings will be held throughout the day.
2. Lake Street BIG8 Investor Conference (September 12, 2024): The company will participate in one-on-one meetings throughout the day.
These conferences provide Spectral AI with opportunities to engage with investors and showcase their AI-driven medical diagnostics technology for wound care treatment decisions.
Spectral AI (Nasdaq: MDAI), un'azienda di intelligenza artificiale specializzata nella diagnosi medica per la cura delle ferite, ha annunciato la sua partecipazione a due prossime conferenze per investitori a New York City. Peter M. Carlson, CEO, e Vince Capone, CFO, rappresenteranno l'azienda in questi eventi:
1. H.C. Wainwright 26th Annual Global Investment Conference (9-11 settembre 2024): Sarà disponibile una chat virtuale a partire dal 9 settembre alle 7:00 ET, accessibile tramite il sito web dell'azienda. Si svolgeranno incontri individuali durante tutta la giornata.
2. Lake Street BIG8 Investor Conference (12 settembre 2024): L'azienda parteciperà a incontri individuali durante tutta la giornata.
Queste conferenze offrono a Spectral AI l'opportunità di interagire con gli investitori e di presentare la loro tecnologia di diagnosi medica basata sull'IA per le decisioni riguardanti il trattamento delle ferite.
Spectral AI (Nasdaq: MDAI), una empresa de inteligencia artificial especializada en diagnósticos médicos para el cuidado de heridas, ha anunciado su participación en dos próximas conferencias de inversionistas en la ciudad de Nueva York. Peter M. Carlson, CEO, y Vince Capone, CFO, representarán a la empresa en estos eventos:
1. H.C. Wainwright 26th Annual Global Investment Conference (9-11 de septiembre de 2024): Se dispondrá de una charla virtual a partir del 9 de septiembre a las 7:00 am ET, accesible a través del sitio web de la empresa. Se llevarán a cabo reuniones uno a uno durante todo el día.
2. Lake Street BIG8 Investor Conference (12 de septiembre de 2024): La empresa participará en reuniones uno a uno a lo largo del día.
Estas conferencias brindan a Spectral AI oportunidades para interactuar con inversionistas y mostrar su tecnología de diagnóstico médico impulsada por IA para decisiones sobre el tratamiento de heridas.
스펙트럴 AI (Nasdaq: MDAI)는 상처 치료를 위한 의료 진단 전문 인공지능 회사로, 뉴욕에서 열리는 두 개의 투자자 회의에 참여한다고 발표했습니다. 피터 M. 칼슨 CEO와 빈스 카폰 CFO가 이 행사에서 회사를 대표할 것입니다:
1. H.C. 웨인라이트 제26회 글로벌 투자 회의 (2024년 9월 9-11일): 9월 9일 오전 7시 ET부터 회사 웹사이트를 통해 액세스할 수 있는 가상 대화가 제공됩니다. 하루 종일 일대일 회의가 진행됩니다.
2. 레이크 스트리트 BIG8 투자 회의 (2024년 9월 12일): 회사는 하루 종일 일대일 회의에 참여할 예정입니다.
이 회의는 스펙트럴 AI가 투자자와 소통하고 AI 기반의 의료 진단 기술을 보여줄 수 있는 기회를 제공합니다.
Spectral AI (Nasdaq: MDAI), une entreprise d'intelligence artificielle spécialisée dans le diagnostic médical pour les soins des plaies, a annoncé sa participation à deux conférences pour investisseurs à venir à New York. Peter M. Carlson, PDG, et Vince Capone, directeur financier, représenteront l'entreprise lors de ces événements :
1. H.C. Wainwright 26th Annual Global Investment Conference (9-11 septembre 2024) : Une discussion virtuelle sera disponible à partir du 9 septembre à 7h00 ET, accessible via le site web de l'entreprise. Des réunions individuelles auront lieu tout au long de la journée.
2. Lake Street BIG8 Investor Conference (12 septembre 2024) : L'entreprise participera à des réunions individuelles tout au long de la journée.
Ces conférences offrent à Spectral AI des opportunités d'interaction avec les investisseurs et de présentation de leur technologie de diagnostic médical basée sur l'IA pour les décisions de traitement des plaies.
Spectral AI (Nasdaq: MDAI), ein Unternehmen für künstliche Intelligenz, das sich auf medizinische Diagnostik für Wundversorgung spezialisiert hat, hat seine Teilnahme an zwei bevorstehenden Investorenkonferenzen in New York City bekannt gegeben. Peter M. Carlson, CEO, und Vince Capone, CFO, werden das Unternehmen auf diesen Veranstaltungen vertreten:
1. H.C. Wainwright 26th Annual Global Investment Conference (9.-11. September 2024): Ein virtueller Austausch wird ab dem 9. September um 7:00 Uhr ET auf der Unternehmenswebsite verfügbar sein. Es werden den ganzen Tag über Einzelgespräche stattfinden.
2. Lake Street BIG8 Investor Conference (12. September 2024): Das Unternehmen wird den Tag über an Einzelgesprächen teilnehmen.
Diese Konferenzen bieten Spectral AI die Möglichkeit, mit Investoren in Kontakt zu treten und ihre KI-gesteuerte medizinische Diagnosetechnologie für Entscheidungen zur Wundversorgung zu präsentieren.
- Participation in two major investor conferences, potentially increasing visibility and investor interest
- Opportunity for one-on-one meetings with investors at both conferences
- Virtual fireside chat available for wider audience reach
- None.
DALLAS, Aug. 28, 2024 (GLOBE NEWSWIRE) -- Spectral AI, Inc. (Nasdaq: MDAI) (“Spectral AI” or the “Company”), an artificial intelligence (AI) company focused on medical diagnostics for faster and more accurate treatment decisions in wound care, today announced that Peter M. Carlson, Chief Executive Officer, and Vince Capone, Chief Financial Officer, are scheduled to participate in the following investor conferences in New York City:
- H.C. Wainwright 26th Annual Global Investment Conference
September 9 – 11, 2024
Virtual Fireside Chat will be available beginning September 9 at 7:00 am ET, by clicking here or by visiting the Investors section of Spectral AI’s website, here
1x1 meetings throughout the day
- Lake Street BIG8 Investor Conference
September 12, 2024
1x1 meetings throughout the day
About Spectral AI
Spectral AI, Inc. is a Dallas-based predictive AI company focused on medical diagnostics for faster and more accurate treatment decisions in wound care, with initial applications involving patients with burns and diabetic foot ulcers. The Company is working to revolutionize the management of wound care by “Seeing the Unknown®” with its DeepView System. The DeepView System is a predictive device that offers clinicians an objective and immediate assessment of a wound’s healing potential prior to treatment or other medical intervention. With algorithm-driven results and a goal to change the current standard of care, the DeepView System is expected to provide faster and more accurate treatment insight towards value care by improving patient outcomes and reducing healthcare costs. For more information about the DeepView System, visit www.spectral-ai.com.
Forward Looking Statements
Certain statements made in this release are “forward looking statements” within the meaning of the “safe harbor” provisions of the United States Private Securities Litigation Reform Act of 1995, including statements regarding the Company’s strategy, plans, objectives, initiatives and financial outlook. When used in this press release, the words “estimates,” “projected,” “expects,” “anticipates,” “forecasts,” “plans,” “intends,” “believes,” “seeks,” “may,” “will,” “should,” “future,” “propose” and variations of these words or similar expressions (or the negative versions of such words or expressions) are intended to identify forward-looking statements.
These forward-looking statements are not guarantees of future performance, conditions or results, and involve a number of known and unknown risks, uncertainties, assumptions and other important factors, many of which are outside Company’s control, that could cause actual results or outcomes to differ materially from those discussed in the forward-looking statements. As such, readers are cautioned not to place undue reliance on any forward-looking statements.
Investors should carefully consider the foregoing factors and the other risks and uncertainties described in the “Risk Factors” sections of the Company’s filings with the SEC, including the Registration Statement and the other documents filed by the Company. These filings identify and address other important risks and uncertainties that could cause actual events and results to differ materially from those contained in the forward-looking statements.
Investors:
The Equity Group
Devin Sullivan
Managing Director
dsullivan@equityny.com
Conor Rodriguez
Analyst
crodriguez@equityny.com
FAQ
When is Spectral AI participating in the H.C. Wainwright Global Investment Conference?
Who will represent Spectral AI at the upcoming investor conferences?
What type of technology does Spectral AI (MDAI) focus on?
When will the virtual fireside chat for Spectral AI be available during the H.C. Wainwright conference?
